Dhvani Rana – Pharmacology – Best Researcher Award

Posted on by Academic achievements

Dhvani Rana - Pharmacology - National Institute of Pharmaceutical Education and Research- Ahmedabad

Dhvani Rana - Pharmacology

Professional Profiles:

Early Academic Pursuits

Dhvani Rana's academic journey commenced with a Bachelor of Pharmacy at L. M. College of Pharmacy under Gujarat Technological University, where she garnered a solid foundation in pharmaceutical sciences, including Pharmaceutics, Pharmaceutical Analysis, Medicinal Chemistry, and more. This early education laid the groundwork for her subsequent pursuit of advanced degrees.

Professional Endeavors

Dhvani continued her academic pursuits at the National Institute of Pharmaceutical Research (NIPER), Ahmedabad, undertaking an M.S. in Pharmaceutics from 2019 to 2021. This period saw her delving into diverse aspects of pharmaceuticals, ranging from Pharmaceutical Preformulation to Controlled Drug Delivery Systems. Dhvani further elevated her academic journey by enrolling in a Ph.D. in Pharmaceutics at NIPER, Ahmedabad, from 2021 onwards. This ongoing endeavor is marked by her dedication, exemplified by a stellar 10 CGPA in the coursework.

Contributions and Research Focus

Dhvani Rana has made notable contributions to the field of Pharmaceutics, particularly in the realm of formulation development. Her research focus encompasses innovative compositions for ophthalmic inserts, the development of nanoliposomes for osteoporosis treatment, and the formulation of intranasal delivery systems for migraine treatment. Dhvani's work involves employing Quality by Design (QbD) approaches, and she has showcased expertise in various analytical techniques and instrumental handling.

Accolades and Recognition

Dhvani's academic prowess and research contributions have earned her esteemed recognition. Notably, she was honored as a Khorana Scholar in 2020, receiving the Khorana Scholar Award from the Department of Biotechnology (DBT), Government of India. Additionally, her excellence in pre-clinical poster presentation was acknowledged with the Dr. B. K. Bacchawat Award, further affirming her standing in the scientific community.

Impact and Influence

Dhvani's impact extends beyond her academic achievements. Selected for an internship at Excelon IP- Patent and Trademark Attorney, she gained practical insights into the application of intellectual property in the pharmaceutical domain. Moreover, her research pursuits, such as the ongoing exploration of novel compositions for ophthalmic inserts, suggest a potential influence on advancing pharmaceutical technologies.

Legacy and Future Contributions

Dhvani Rana's legacy is in the making as she continues her Ph.D. at NIPER, Ahmedabad. Her dedication to quality research, innovative formulations, and contributions to intellectual property augur well for her future impact in the pharmaceutical sciences. With a robust foundation in both academia and practical application, Dhvani is poised to make enduring contributions to the scientific community, particularly in Pharmaceutics, and leave a lasting legacy in the field.

Notable Publications :

Functionalized Carbon Nanotubes for Cell Tracking 2023

In Vivo Evaluation of Almotriptan malate Formulation through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment 2023

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis 2023

Precise Fabrication of Ocular Inserts Using an Innovative Laser-Driven CaliCut Technology: In Vitro and In Vivo Evaluation 2023-12

Mo’tasem Alsmadi – Biopharmaceutics – Best Researcher Award – 5740

Posted on by Academic achievements

Mo'tasem Alsmadi - Biopharmaceutics-Jordan University of Science & Technology

Mo'tasem Alsmadi - Biopharmaceutics

Professional Profiles:

Early Academic Pursuits:

Mo'tasem Alsmadi embarked on his academic journey at the Jordan University of Science & Technology, laying the foundation for his future endeavors. His early academic pursuits reflect a commitment to knowledge acquisition and a passion for scientific exploration.

Professional Endeavors:

Building on his academic foundation, Mo'tasem ventured into professional endeavors that showcased his dedication to his field. Gaining practical experience and applying theoretical knowledge, he demonstrated a holistic approach to the integration of academia and real-world applications.

Contributions and Research Focus:

Mo'tasem Alsmadi's contributions to academia and research are characterized by a focused and dedicated approach. His research focus at the Jordan University of Science & Technology exemplifies his commitment to advancing knowledge within his field. Whether through publications, projects, or collaborations, Mo'tasem has actively contributed to the academic community.

Accolades and Recognition:

Throughout his academic and professional journey, Mo'tasem Alsmadi has garnered accolades and recognition for his outstanding contributions. These accolades serve as a testament to the quality and impact of his work, earning him respect and acknowledgment from peers and institutions alike.

Impact and Influence:

Mo'tasem's impact extends beyond individual achievements. His influence is marked by the positive changes and advancements he has brought to his field. Whether through innovative research, mentorship, or collaborative efforts, Mo'tasem has left an indelible mark on the academic and professional landscape.

Legacy and Future Contributions:

As Mo'tasem Alsmadi continues to progress in his academic and professional journey, he leaves behind a legacy of excellence and dedication. His future contributions hold the promise of further innovation and positive impact. Mo'tasem is poised to be a driving force in shaping the future landscape of his field, leaving a lasting legacy for future generations.

Notable Publications :

Evaluating the Pharmacokinetics of Fentanyl in the Brain Extracellular Fluid, Saliva, Urine, and Plasma of Newborns from Transplacental Exposure from Parturient Mothers Dosed with Epidural Fentanyl Utilizing PBPK Modeling 2023 Sep;48(5)

The In Vitro, In Vivo, and PBPK Evaluation of a Novel Lung-Targeted Cardiac-Safe Hydroxychloroquine Inhalation Aerogel 2023 Aug 11;24(6)

In vitro–in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to human 2023 Jun;44(3)

The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling 2022 Oct 10;38(1)